GSK said that the data so far suggests they could be “best-in-class” new vaccines that could “change the standard of care.” “With this new agreement, we will apply GSK’s capabilities ...
GSK meanwhile has previously suggest that the HBV therapy could collectively achieve sales of more than £2 billion ($2.45 billion) at peak, part of a new wave of therapies that it reckons could ...
Why Federal Courts May Be the Last Bulwark Against Trump With a compliant Congress and mostly quiet streets, President Trump’s opponents are turning to a flurry of legal actions. But can the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback